Xinqiao Hospital Of Chongqing

This early-phase study tests a new mRNA drug that targets a protein called CD19 on cancer cells. It is for adults aged 18–70 with B-cell lymphoma or leukemia who have no standard treatment options left. The drug is given by IV or injection and aims to control the disease by helpi…

This study tests two drugs, tirofiban and alteplase, given before a procedure to remove a large blood clot in the brain during a stroke. About 800 adults with acute ischemic stroke will be randomly assigned to receive one of the drugs. The goal is to see which drug leads to bette…

This study is testing whether giving a clot-busting drug (rhTNK-tPA) before a surgical procedure to remove a stroke-causing blood clot leads to better recovery. It focuses on patients who arrive at the hospital 4.5 to 24 hours after their stroke symptoms began. Researchers will c…

This study looks at whether a simple CT scan can be used instead of more advanced scans to decide if stroke patients should have a procedure to remove a blood clot. About 1,846 adults who had a stroke within the last 24 hours will take part. The goal is to see if the simple scan …